Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and ...
Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welf...
Singapore: Orient EuroPharma, a specialty pharmaceutical company focused in marketing and commercialization has partnere...
Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that...
Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon sta...
Rock Creek Pharmaceuticals Inc, a clinical-stage drug development company focused on the application of its lead compoun...
Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected wi...
Singapore: Laboratory Corporation of America has released 4th generation HIV antigen/antibody combination assay and a ne...
Japan's pharma giant, Chugai Pharmaceutical Co. has reported that the US Food and Drug Administration (FDA) has granted ...
Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove mali...
Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-fr...
The US subsidiary of Osaka-based Shionogi has announced results of its pivotal phase III study (COMPOSE I). The study re...
Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro d...
Singapore: China based CARsgen Therapeutics, a private and venture backed company focused on the development of CAR-T-ba...
Singapore: Actavis has recieved US Federal Trade Commission (FTC) nod to acquire Forest Laboratories following a propose...
Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new...
Singapore: Kowa Pharmaceuticals and Eli Lilly released results from a pharmacokinetic (PK) study exploring potential dru...
Singapore: Taiwan based TWi Biotechnology has received patent allowance for AC-201, its lead drug candidate, from the Eu...
